Anaphylaxis is an acute life-threatening systemic allergic reaction that can have a wide
range of clinical manifestations. The most common triggers for anaphylaxis include food …

Chemotherapy-induced peripheral neuropathy (CIPN) often develops in patients with cancer
treated with commonly used anti-cancer drugs. The symptoms of CIPN can occur acutely …

Chronic pain is an enormous public health concern, and its treatment is still an unmet
medical need. Starting from data highlighting the promising effects of some nonsteroidal anti …

Cancer chemotherapy-induced neuropathic pain is a devastating pain syndrome without
effective therapies. We previously reported that rats deficient in complement C3, the central …

Risk stratification in drug allergy implies that specific risk categories (eg, low, moderate, and
high) classify historical drug hypersensitivity reactions. These risk categories can be based …

Chemotherapy-induced neuropathic pain (CINP) is one of the most prominent and
incapacitating complication associated with chemotherapeutic regimens. The exact …

Background Tumor local and distant relapse recurrence after radiotherapy (RT) is one of the
critical factors leading to poor prognosis. The effective antitumor effects of RT are dependent …

Chemotherapy-induced peripheral neuropathy (CIPN) is the most common neurologic
complication of chemotherapy, resulting in symptoms like pain, sensory loss, and numbness …

Peripheral neuropathy is a common adverse effect associated with the use of a group of
chemotherapeutic agents including paclitaxel (PTX) which negatively affect the quality of life …

Many anti-cancer drugs, such as taxanes, platinum compounds, vinca alkaloids, and
proteasome inhibitors, can cause chemotherapy-induced peripheral neuropathy (CIPN) …